Fujifilm’s IP dynamism is securing its future – and could save human lives along the way
A drug developed by a subsidiary of Fujifilm has shown some efficacy in the treatment of patients infected with the extremely contagious – and usually deadly – ebola virus, according to recent reports. The compound – Favipiravir – is manufactured by…
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Register now
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.
Subscribe now